Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Westwood-Squibb was a prominent dermatology-focused pharmaceutical company and a division of Bristol Myers Squibb. Formed through the integration of Westwood Pharmaceuticals and Squibb's dermatological interests, the company specialized in developing and marketing topical treatments for skin conditions such as psoriasis, acne, and fungal infections. Its product portfolio included well-known brands like Dovonex, Lac-Hydrin, and Desquam. While the Westwood-Squibb name was a leader in the dermatology market for decades, Bristol Myers Squibb eventually divested much of its dermatology business to focus on core therapeutic areas like oncology and immunology. The company's legacy remains through its widely recognized products, many of which continue to be marketed by other pharmaceutical entities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Westwood Squibb.